ELVORINE 175 mg/17.5 ml, solution for injection bottle, 17.5 ml
Active ingredients: ACIDE L FOLINIQUE, Levoleucovorin calcium
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 17.5 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ELVORINE 175 mg/17,5 mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 flacon(s) en verre brun de 17,5 ml
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 May 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63784708CIP73489912CIP133400934899126Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE L FOLINIQUEsolution | 175,00 mg · un flacon | FT |
| LÉVOFOLINATE DE CALCIUMsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.